Innate immunity in coronavirus infection

21Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Coronaviruses (CoVs) comprise a polymorphic group of respiratory viruses causing acute inflammatory diseases in domestic and agricultural animals (chicken, pig, buffalo, cat, dog). Until recently, this infection in humans was mainly observed during the autumn-winter period and characterized by a mild, often asymptomatic, course. The situation changed dramatically in 2003, when SARS outbreak caused by pathogenic CoV (SARS-CoV) was recorded in China. A decade later, a new CoV outbreak occurred in the form of the Middle East respiratory syndrome (MERS-CoV), whereas in December 2019, SARS-CoV-2 (COVID-19) cases were recorded, which transformed within the first months of 2020 into the pandemic. In all three cases, CoV disease led to severe bronchopulmonary lesions, varying from dry, debilitating cough to acute respiratory distress syndrome (ARDS). At the same time, multiple changes in innate immunity were noted most often manifested as a pronounced inflammatory reaction in the lower respiratory tract, featured by damaged type II pneumocytes, apoptosis, hyalinization of alveolar membranes, focal or generalized pulmonary edema. Destructive processes in the respiratory tract were accompanied by migration of monocytes/macrophages and granulocyte neutrophils to the inflammatory focus. Such events were accompanied by production of pro-inflammatory cytokines, which magnitude could ascend up to a cytokine storm. SARS-CoV is characterized by symptoms of secondary immunosuppression, manifested by the late onset of interferon production and activation of NLRP3 inflammasomes – the key inflammatory factor. The reason for such reaction may be accounted for by CoV arsenal containing extensive set of structural and non-structural proteins exerting pro-inflammatory and immunosuppressive properties. Delayed IFN production allowed CoV to replicate actively and freely, and when type I IFN synthesis was eventually triggered, its activity was detrimental and accompanied by an aggravated infection course. Thus, SARS can surely be referred to immune-dependent infections with a marked immunopathological component. The purpose of this review was to describe some mechanisms underlying formation of innate immune response to infection caused by pathogenic coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19).

References Powered by Scopus

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

3798Citations
N/AReaders
Get full text

Origin and evolution of pathogenic coronaviruses

3777Citations
N/AReaders
Get full text

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- A n update on the status

3181Citations
N/AReaders
Get full text

Cited by Powered by Scopus

COVID-19: Oxidative stress and the relevance of antioxidant therapy

18Citations
N/AReaders
Get full text

SOME OPPORTUNITIES for IMMUNOTHERAPY in CORONAVIRUS INFECTION

15Citations
N/AReaders
Get full text

COVID-19 and children

15Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Smirnov, V. S., & Totolian Areg, A. (2020). Innate immunity in coronavirus infection. Russian Journal of Infection and Immunity. Saint Petersburg Pasteur Institute. https://doi.org/10.15789/2220-7619-III-1440

Readers over time

‘20‘21‘22‘23‘24‘2507142128

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

78%

Researcher 2

22%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

62%

Nursing and Health Professions 3

23%

Pharmacology, Toxicology and Pharmaceut... 1

8%

Social Sciences 1

8%

Save time finding and organizing research with Mendeley

Sign up for free
0